drugset / Trial / NCT07086287

Evaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery

NCT07086287 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

evaluation of the efficacy of recombinant human brain natriuretic peptide in patients with diuretic resistance after cardiac surgery: a prospective single-center single-blind randomized controlled study

Timeline

Start
2025-08-01
Primary completion
2026-11-30
Completion
2028-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject rhBNP Peptide 0.0075 ug/kg Intravenous
Subject rhBNP Peptide 0.01 ug/kg Intravenous

Indications

No indication recorded.